Stefano Del Prato

55.6k total citations · 14 hit papers
528 papers, 27.4k citations indexed

About

Stefano Del Prato is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Stefano Del Prato has authored 528 papers receiving a total of 27.4k indexed citations (citations by other indexed papers that have themselves been cited), including 331 papers in Endocrinology, Diabetes and Metabolism, 183 papers in Surgery and 154 papers in Molecular Biology. Recurrent topics in Stefano Del Prato's work include Diabetes Treatment and Management (207 papers), Diabetes Management and Research (181 papers) and Metabolism, Diabetes, and Cancer (137 papers). Stefano Del Prato is often cited by papers focused on Diabetes Treatment and Management (207 papers), Diabetes Management and Research (181 papers) and Metabolism, Diabetes, and Cancer (137 papers). Stefano Del Prato collaborates with scholars based in Italy, United States and United Kingdom. Stefano Del Prato's co-authors include Piero Marchetti, Steven E. Kahn, Mark E. Cooper, Ralph A. DeFronzo, R Lupi, Roberto Miccoli, Antonio Tiengo, S Del Guerra, Ugo Boggi and Giuseppe Penno and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Stefano Del Prato

512 papers receiving 26.7k citations

Hit Papers

Pathophysiology and treat... 2007 2026 2013 2019 2013 2021 2022 2009 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
    2013 1.2k citations Stefano Del Prato et al. profile →
  2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
    2021 815 citations Naveed Sattar, Kelley R. Branch et al. profile →
  3. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2022 810 citations Stefano Del Prato et al. Diabetes Care profile →
  4. How Do We Define Cure of Diabetes?
    2009 734 citations Antonio Ceriello, Stefano Del Prato et al. Diabetes Care profile →
  5. COVID-19 in people with diabetes: understanding the reasons for worse outcomes
    2020 584 citations A Coppelli, Stefano Del Prato et al. profile →
  6. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
    2007 569 citations R Lupi, Piero Marchetti et al. profile →
  7. New-Onset Diabetes in Covid-19
    2020 518 citations Stefano Del Prato, Kamlesh Khunti et al. profile →
  8. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2022 488 citations Stefano Del Prato et al. Diabetologia profile →
  9. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
    2021 456 citations Hertzel C. Gerstein, Naveed Sattar et al. profile →
  10. Management of type 2 diabetes: new and future developments in treatment
    2011 422 citations Stefano Del Prato et al. profile →
  11. Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin
    2011 415 citations Stefano Del Prato et al. Diabetes Care profile →
  12. COVID-19, Hyperglycemia, and New-Onset Diabetes
    2021 170 citations Kamlesh Khunti, Stefano Del Prato et al. Diabetes Care profile →
  13. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
    2022 165 citations Stefano Del Prato et al. Diabetologia profile →
  14. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
    2023 105 citations Stefano Del Prato, Naveed Sattar et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stefano Del Prato 15.0k 9.5k 8.1k 4.7k 3.5k 528 27.4k
Mark E. Cooper 17.4k 1.2× 5.8k 0.6× 11.4k 1.4× 5.3k 1.1× 2.3k 0.6× 506 47.5k
K. G. M. M. Alberti 15.6k 1.0× 5.0k 0.5× 5.6k 0.7× 6.7k 1.4× 3.2k 0.9× 237 32.5k
Weiping Jia 8.4k 0.6× 4.4k 0.5× 10.1k 1.2× 5.1k 1.1× 2.8k 0.8× 738 27.2k
Per‐Henrik Groop 9.5k 0.6× 4.3k 0.5× 5.7k 0.7× 4.1k 0.9× 4.0k 1.1× 519 22.4k
Santica M. Marcovina 11.2k 0.7× 12.1k 1.3× 3.3k 0.4× 2.3k 0.5× 4.2k 1.2× 405 24.6k
Steven E. Kahn 20.4k 1.4× 12.6k 1.3× 12.4k 1.5× 13.0k 2.8× 5.8k 1.6× 467 45.2k
Leif Groop 14.2k 0.9× 9.7k 1.0× 12.1k 1.5× 7.3k 1.6× 10.0k 2.8× 548 35.5k
Ronald M. Krauss 18.0k 1.2× 12.8k 1.4× 7.7k 0.9× 9.5k 2.0× 4.1k 1.2× 378 47.3k
Ralph A. DeFronzo 18.9k 1.3× 8.0k 0.8× 13.3k 1.6× 11.6k 2.5× 2.8k 0.8× 282 37.6k
Peter H. Bennett 14.5k 1.0× 5.3k 0.6× 5.7k 0.7× 7.0k 1.5× 4.3k 1.2× 288 34.6k

Countries citing papers authored by Stefano Del Prato

Since Specialization
Citations

This map shows the geographic impact of Stefano Del Prato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Del Prato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Del Prato more than expected).

Fields of papers citing papers by Stefano Del Prato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Del Prato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Del Prato. The network helps show where Stefano Del Prato may publish in the future.

Co-authorship network of co-authors of Stefano Del Prato

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Del Prato. A scholar is included among the top collaborators of Stefano Del Prato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Del Prato. Stefano Del Prato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rutter, Martin K., Matthew Carr, Alison K. Wright, et al.. (2024). Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally. Diabetes Research and Clinical Practice. 212. 111693–111693. 1 indexed citations
2.
Januzzi, James L., Stefano Del Prato, Julio Rosenstock, et al.. (2024). Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial. Cardiovascular Diabetology. 23(1). 49–49. 11 indexed citations
3.
Gilbert, Matthew P., Joan M. Skelly, Adrian F. Hernandez, et al.. (2024). Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial. Diabetes Obesity and Metabolism. 26(5). 1714–1722. 2 indexed citations
4.
Prato, Stefano Del, et al.. (2023). Application of SERS Spectroscopy for the Study of Biological Molecules. SHILAP Revista de lepidopterología. 27–27. 2 indexed citations
5.
Rosenstock, Julio, Luis Alberto Vázquez, Stefano Del Prato, et al.. (2023). Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials. Diabetes Care. 46(11). 1986–1992. 14 indexed citations
6.
Dardano, Angela, et al.. (2022). Effect of fasting on short‐term visual plasticity in adult humans. European Journal of Neuroscience. 57(1). 148–162. 6 indexed citations
7.
Lam, Carolyn S.P., Chinthanie Ramasundarahettige, Kelley R. Branch, et al.. (2021). Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. Circulation. 145(8). 565–574. 77 indexed citations
8.
Ray, Kausik K., Lawrence A. Leiter, Dirk Müller‐Wieland, et al.. (2018). Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial. Diabetes Obesity and Metabolism. 20(6). 1479–1489. 69 indexed citations
9.
Prato, Stefano Del, et al.. (2013). Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin. SHILAP Revista de lepidopterología. 9 indexed citations
10.
11.
Dotta, Francesco, Stefano Censini, Astrid G. S. van Halteren, et al.. (2007). Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proceedings of the National Academy of Sciences. 104(12). 5115–5120. 415 indexed citations
12.
Cianni, Graziano Di, Giuseppe Seghieri, Cristina Lencioni, et al.. (2007). Normal Glucose Tolerance and Gestational Diabetes Mellitus. Diabetes Care. 30(7). 1783–1788. 59 indexed citations
13.
Lupi, R, R Mancarella, S Del Guerra, et al.. (2006). The direct effects of exendin-4 on human non-diabetic and type 2 diabetic islets. Diabetologia. 49. 303–304. 1 indexed citations
14.
Vistoli, Fabio, A Coppelli, Ugo Boggi, et al.. (2005). PANCREAS TRANSPLANT ALONE IMPROVES DIABETIC NEPHROPATHY. American Journal of Transplantation. 5. 267–267. 4 indexed citations
15.
Grupillo, Maria, S Del Guerra, Matilde Masini, et al.. (2005). Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress. Diabetologia. 48. 1 indexed citations
16.
Prato, Stefano Del, R Lupi, Marco Bugliani, et al.. (2004). Glucotoxicity in human pancreatic islets is mediated by oxidative stress: evidence for limited defense capacity. Diabetologia. 47. 1 indexed citations
17.
Marchetti, Piero, S Del Guerra, R Lupi, et al.. (2002). Function and survival of islets prepared from the pancreas of Type 2 diabetic patients. Diabetologia.
18.
Santis, Laura De, F. J. Davey, Stefano Del Prato, & Giuliano Brancolini. (2001). Subsidence at the Cape Roberts Project (CRP) Drillsites from Backstripping Techniques, Victoria Land Basin, Antarctica. Helmholtz-Zentrum für Polar-und Meeresforschung (Alfred-Wegener-Institut). 2 indexed citations
19.
Lupi, R, S Del Guerra, Vanna Fierabracci, et al.. (2001). Lipotoxicity in human pancreatic islets and the effects of metformin. Diabetes. 44. 1 indexed citations
20.
Tuomilehto, J & Stefano Del Prato. (2001). MEALTIME GLUCOSE REGULATION IN TYPE 2 DIABETES. International Journal of Clinical Practice. 55(6). 380–383. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark E. Cooper Breakdown of academic impact, for papers by K. G. M. M. Alberti Breakdown of academic impact, for papers by Weiping Jia Breakdown of academic impact, for papers by Per‐Henrik Groop Breakdown of academic impact, for papers by Santica M. Marcovina Breakdown of academic impact, for papers by Steven E. Kahn Breakdown of academic impact, for papers by Leif Groop Breakdown of academic impact, for papers by Ronald M. Krauss Breakdown of academic impact, for papers by Ralph A. DeFronzo Breakdown of academic impact, for papers by Peter H. Bennett
Rankless by CCL
2026